| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 01/09/2002 | CN1077566C 1-phenyl-3-dimethylaminopropane compounds with pharmacological effect |
| 01/08/2002 | US6337423 Bind to voltage-gated sodium ion channels to modulate activity |
| 01/08/2002 | US6337422 Yellow polymorph of 5-amino-2,4,6-triiodo-n,n′-bis(2-3-dihydroxypropy)-isophthalamide |
| 01/08/2002 | US6337350 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 01/03/2002 | WO2002000612A1 Glucagon antagonists/inverse agonists |
| 01/03/2002 | WO2002000606A1 Biphenyl compound |
| 01/03/2002 | US20020002199 Suitable for treating type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance or obesity |
| 01/03/2002 | US20020001591 Compositions for the delivery of antigens |
| 01/03/2002 | CA2411552A1 Glucagon antagonists/inverse agonists |
| 01/02/2002 | EP1167356A2 Wet adhesion monomer and derived copolymers for latex paints |
| 01/02/2002 | EP1166781A1 Proteasome inhibitors |
| 01/02/2002 | EP1165515A1 Pyridine-2,3-dicarboxylic acid diamides |
| 01/02/2002 | EP1165496A1 Substituted aniline compounds |
| 01/02/2002 | EP1165494A2 Hsv primase inhibitors |
| 01/02/2002 | EP1165493A1 Nitrogen mustard compounds and prodrugs therefor |
| 01/02/2002 | EP1165492A1 Hydroxyphenyl derivatives with hiv integrase inhibitory properties |
| 01/02/2002 | EP1165064A2 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 01/01/2002 | US6335468 Process for production N-acyl amino acid amide |
| 01/01/2002 | US6335199 Gene therapy |
| 12/27/2001 | WO2001098260A1 7-n-substituted phenyl tetracycline compounds |
| 12/27/2001 | WO2001098259A1 7-phenyl-substituted tetracycline compounds |
| 12/27/2001 | WO2001098256A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 12/27/2001 | WO2001098248A2 Hiv integrase inhibitors |
| 12/27/2001 | WO2001098236A2 7-phenyl-substituted tetracycline compounds |
| 12/27/2001 | WO2001028979A3 Inhibitors of neuraminidases |
| 12/27/2001 | US20010056206 Process for the preparation of iopamidol |
| 12/27/2001 | CA2412985A1 Hiv integrase inhibitors |
| 12/26/2001 | CN1328539A Process for preparation of N,N'-bis [2,3-dihydroxypropyl]-5-[(hydroxyacetyl)methylamino]-2,4,6-triiodo-1,3-benzenedi carboxamide |
| 12/25/2001 | US6333432 Fungicidal compositions and methods, and compounds and methods for the preparation thereof |
| 12/25/2001 | US6333358 Aryloxyaniline derivatives |
| 12/25/2001 | US6333176 Enzymatic cleavage of c-terminal amino group from peptide amide, deamination with peptide amidase, incubation and inoculation |
| 12/20/2001 | WO2001097217A2 Optical storage using materials comprising chromophore oligomers which can undergo cycloaddition |
| 12/20/2001 | WO2001096305A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096297A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/20/2001 | WO2001096283A2 Hiv integrase inhibitors |
| 12/20/2001 | WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents |
| 12/20/2001 | WO2001051456A3 Antibacterial agents |
| 12/20/2001 | WO2001046121A3 Exciplexes |
| 12/20/2001 | CA2412857A1 Hiv integrase inhibitors |
| 12/20/2001 | CA2412618A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/20/2001 | CA2412615A1 Optical storage using materials comprising chromophore oligomers which can undergo cycloaddition |
| 12/19/2001 | EP1163247A1 Pharmaceutical compositions comprising metal complexes |
| 12/19/2001 | EP1163212A1 Amide derivatives |
| 12/19/2001 | EP1163208A2 Caspase inhibitors and uses thereof |
| 12/19/2001 | EP0721449B1 Inhibitors of beta-amyloid protein production |
| 12/19/2001 | CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 12/18/2001 | US6331640 Diaminopropionic acid derivatives |
| 12/18/2001 | US6331636 Treatment of central nervous system disorders, diabetes, hypertension, impotency, appetite control |
| 12/18/2001 | US6331624 Process for preparing 6-aminocaproamide |
| 12/18/2001 | US6331607 Reacting an n-subsituted propylenediamine and a 2-aminoglutaric acid derivative in the presence of an aminosilicone |
| 12/18/2001 | US6331318 Carbon-substituted diketopiperazine delivery systems |
| 12/13/2001 | WO2001094357A1 Antitumoral compounds |
| 12/13/2001 | WO2001094307A1 Propanolaminotetralines, preparation thereof and compositions containing same |
| 12/13/2001 | WO2001094295A1 Substituted stilbenes as glucose uptake enhancers |
| 12/13/2001 | WO2001094294A1 Fungicides |
| 12/13/2001 | US20010051626 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 12/13/2001 | US20010051623 8-(Piperidin-4-yl- or piperazin-1-yl)-2-substituted-tetralin derivatives; selective effect at a subgroup of 5-hydroxytryptamine receptors, h5-HT1B receptors (previously 5-HT1D beta); antagonists; mood disorders, antianxiolytic |
| 12/13/2001 | DE19910396C2 Anthranilsäureamide und deren Verwendung als Arzneimittel Anthranilic acid amides and their use as medicaments |
| 12/13/2001 | CA2411340A1 Substituted stilbenes as glucose uptake enhancers |
| 12/13/2001 | CA2410409A1 Antitumoral compounds |
| 12/12/2001 | EP1161421A1 Inhibitors of protein tyrosine phosphatase |
| 12/12/2001 | EP0925275B1 Process for iohexol manufacture |
| 12/12/2001 | EP0851854B1 Process for the purification of an intermediate in the preparation of iopamidol |
| 12/12/2001 | EP0781126B1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system |
| 12/11/2001 | US6329546 Caged amino acids |
| 12/11/2001 | US6329377 Enzyme inhibitors for nervous system disorders |
| 12/11/2001 | US6329373 Metalloproteinase inhibitors |
| 12/11/2001 | US6329360 Hetero-linked phenylglycinolamides |
| 12/11/2001 | US6329143 Providing a substrate having surface bearing multiple copies of a protective group removable on exposure to an electric field or electric current; applying electric field or current to substrate; exposing to protected monomer, repeating |
| 12/06/2001 | WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents |
| 12/06/2001 | WO2001092212A1 Excitatory amino acid receptor modulators |
| 12/06/2001 | WO2001092211A1 Compounds exhibiting thrombopoietin-like activities |
| 12/06/2001 | WO2001092210A1 Compounds for modulating the rage receptor |
| 12/06/2001 | CA2599562A1 Compounds for modulating the rage receptor |
| 12/06/2001 | CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 12/05/2001 | EP1159261A2 Antizyme modulators and their use |
| 12/05/2001 | EP1159260A1 Novel compounds and compositions as protease inhibitors |
| 12/05/2001 | EP1158996A1 Novel amide derivatives as growth hormone secretagogues |
| 12/05/2001 | CN1325384A Anthranilic acid amides and the use thereof as medicaments |
| 12/05/2001 | CN1325380A Benzene derivatives and medical use thereof |
| 12/04/2001 | US6326393 Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases |
| 12/04/2001 | CA2278883C Very large scale immobilized peptide synthesis |
| 12/04/2001 | CA2171882C Inhibitors of .beta.-amyloid protein production |
| 11/29/2001 | WO2001090048A1 Preparation of enantiomerically enriched amine-functionalized compounds |
| 11/29/2001 | WO2001090047A1 Novel mmp-2/mmp-9 inhibitors |
| 11/29/2001 | US20010046975 Fungicides for the control of take-all disease of plants |
| 11/29/2001 | US20010046960 N-(2,2,2-trifluoroethyl)glycine derivatives; can be used to prepare lipophilic proteins adapted for crossing the blood brain barrier |
| 11/29/2001 | CA2410593A1 Novel mmp-2/mmp-9 inhibitors |
| 11/28/2001 | EP1157002A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy |
| 11/28/2001 | EP0837845B1 Herpes ribonucleotide reductase inhibitors |
| 11/27/2001 | US6323243 Aromatic ether with amine or amide groups |
| 11/27/2001 | US6323202 Benzamide substitutes with ketone compounds as enzyme inhibitors |
| 11/22/2001 | WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents |
| 11/22/2001 | WO2001087838A1 Cyclohexane derivatives and their use as therapeutic agents |
| 11/22/2001 | WO2001087824A2 7-substituted fused ring tetracycline compounds |
| 11/22/2001 | WO2001087823A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives |
| 11/22/2001 | WO2001087819A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE α-AMINO ACID AND OPTICALLY ACTIVE α-AMINO ACID AMIDE |
| 11/22/2001 | WO2001087299A1 Aralkyl ester soft drugs |
| 11/22/2001 | WO2001032691A8 Hcv ns3 protease inhibitors |
| 11/22/2001 | US20010044547 From l-mannonic-gamma-lactone intermediates; for prophylaxis of HIV/AIDS HIV |